A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
Kimberley Steele, M.D., Ph.D., ARPA-H Program Manager, will join the Investor Catalyst Hub and Customer Experience Hub for an information session to discuss ARPA-H’s new Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) program, which envisions a future where doctors have a wide variety of therapeutic tools targeting abnormal lymphatic structure and function. GLIDE aims to advance lymphatic medicine, improve our understanding of the role of lymphatic dysfunction in disease, and build effective, affordable, and accessible treatment options.
Save your spot now to learn more about the program!
This event is open only to current IC Hub and CX Hub spoke members.